BREAST DUCTAL CARCINOMA IN SITU
Clinical trials for BREAST DUCTAL CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new BREAST DUCTAL CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for BREAST DUCTAL CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can fasting plus a diabetes drug shrink breast tumors?
Disease control OngoingThis study looks at whether combining a nightly fasting period with the diabetes drug metformin can slow the growth of early-stage breast cancer. About 120 women with hormone-sensitive breast cancer or a pre-cancer condition called DCIS will follow a fasting schedule and take met…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:51 UTC
-
Could a gel help fight breast cancer? new trial tests endoxifen
Disease control OngoingThis early-phase trial is testing a gel form of the drug endoxifen on the breast skin of 32 women scheduled for mastectomy. The goal is to find the safest dose and see how much drug gets into breast tissue. The study compares the gel to a placebo to understand side effects and po…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Landmark study refines chemo use for common breast cancer
Disease control OngoingThis large phase 3 trial studied over 5,000 women with hormone receptor-positive, HER2-negative breast cancer that had spread to 1-3 lymph nodes. Participants received standard hormone therapy (tamoxifen or aromatase inhibitors) either alone or with chemotherapy. The goal was to …
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Battle of the creams: aquaphor vs miaderm for radiation burns
Symptom relief OngoingThis study compares two skin creams, Aquaphor and Miaderm, to see which one better treats the painful skin rash caused by radiation therapy in breast cancer patients. About 208 women getting radiation after breast cancer surgery will use one of the creams and report their skin re…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated May 26, 2026 07:01 UTC